PSYCH OpenIR  > 中国科学院心理健康重点实验室
P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naive schizophrenia
Xia, Luyao1,2; Wang, Dongmei1,2; Wei, Gaoxia1,2; Wang, Jiesi1,2; Zhou, Huixia1,2; Xu, Hang1,2; Tian, Yang1,2; Dai, Qilong1,2; Xiu, Meihong3; Chen, Dachun3; Wang, Li1,2; Zhang, Xiangyang1,2
第一作者Xia, Luyao
通讯作者邮箱zhangxy@psych.ac.cn (x. zhang)
心理所单位排序1
摘要

Background: Many studies have announced that P50 inhibition defects represent sensory gating deficits in schizophrenia, but studies seldom have searched the correlation between P50 inhibition defects and the psychopathology or cognitive impairment of patients with first-episode, drug naive (FEDN) of schizophrenia. In this study, we investigated the auditory sensory gating deficits in a large number of Han patients with FEDN schizophrenia and their correlation with clinical symptoms and cognitive impairment. Methods: A total of 130 patients with FEDN schizophrenia and 189 healthy controls were recruited in this study. Positive and Negative Syndrome Scale (PANSS) and its five-factor model were used to score the psychopathology of the patients, and P50 inhibition was recorded using the 64-channel electroencephalography (EEG) system. Results: Patients exhibited significantly longer S1 and S2 latency, lower S1 and S2 amplitudes and lower P50 difference than healthy controls (all p < 0.05). Significant correlations existed between S1 latency and PANSS negative symptoms or cognitive factor, P50 ratio and general psychopathology, P50 ratio and PANSS total score, P50 difference and general psychopathology, and P50 difference and PANSS total score (all p < 0.05). Multiple regression analysis revealed that S1 latency, sex, age, and education were contributors to negative symptom score (all p < 0.05). S1 latency, S2 latency, sex, age, and smoking status were contributors to cognitive factor (all p < 0.05). Conclusions: Our results show that patients with FEDN schizophrenia have P50 inhibition defects, which may be related to their psychopathological symptoms and cognitive impairment.

关键词Schizophrenia P50 Sensory gating Auditory evoked potential Cognition
2021-04-20
DOI10.1016/j.pnpbp.2021.110246
发表期刊PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
ISSN0278-5846
卷号107页码:7
期刊论文类型实证研究
收录类别SCI
出版者PERGAMON-ELSEVIER SCIENCE LTD
WOS研究方向Neurosciences & Neurology ; Pharmacology & Pharmacy ; Psychiatry
WOS类目Clinical Neurology ; Neurosciences ; Pharmacology & Pharmacy ; Psychiatry
WOS记录号WOS:000617280700016
WOS分区Q1
引用统计
被引频次:6[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.psych.ac.cn/handle/311026/38569
专题中国科学院心理健康重点实验室
通讯作者Zhang, Xiangyang
作者单位1.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China
2.Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China
3.Peking Univ, Beijing HuiLongGuan Hosp, Beijing, Peoples R China
第一作者单位中国科学院心理健康重点实验室
通讯作者单位中国科学院心理健康重点实验室
推荐引用方式
GB/T 7714
Xia, Luyao,Wang, Dongmei,Wei, Gaoxia,et al. P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naive schizophrenia[J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY,2021,107:7.
APA Xia, Luyao.,Wang, Dongmei.,Wei, Gaoxia.,Wang, Jiesi.,Zhou, Huixia.,...&Zhang, Xiangyang.(2021).P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naive schizophrenia.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY,107,7.
MLA Xia, Luyao,et al."P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naive schizophrenia".PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 107(2021):7.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
P50 inhibition defec(1176KB)期刊论文出版稿限制开放CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xia, Luyao]的文章
[Wang, Dongmei]的文章
[Wei, Gaoxia]的文章
百度学术
百度学术中相似的文章
[Xia, Luyao]的文章
[Wang, Dongmei]的文章
[Wei, Gaoxia]的文章
必应学术
必应学术中相似的文章
[Xia, Luyao]的文章
[Wang, Dongmei]的文章
[Wei, Gaoxia]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。